BBC News·4 min read·medium
FDA panel loosens restrictions for controversial peptides popular online
H
https://www.facebook.com/bbcnews
✦AI Summary
A US FDA advisory panel has voted to loosen restrictions on the production of certain controversial peptides, such as BPC-157 and TB-500. These substances have gained popularity in online wellness communities for unproven health and performance benefits, despite warnings from health experts regarding their safety.
Image source, Getty Images By Madeline Halpert and Kathryn Armstrong Published 23 July 2026 A US Food and Drug Administration (FDA) advisory panel has voted to loosen restrictions on controversial peptides that have become popular online, but have not been well researched for human usage.
healthsciencepolitics
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in